Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
- PMID: 31357896
- PMCID: PMC6711028
- DOI: 10.1080/10717544.2019.1642420
Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
Abstract
Lipid-polymer hybrid nanoparticles (LPHNP) are delivery systems for controlled drug delivery at tumor sites. The superior biocompatible properties of lipids and structural advantages of polymers can be obtained using this system for controlled drug delivery. In this study, cisplatin-loaded lipid-chitosan hybrid nanoparticles were formulated by the single step ionic gelation method based on ionic interaction of positively charged chitosan and negatively charged lipid. Formulations with various chitosan to lipid ratios were investigated to obtain the optimal particle size, encapsulation efficiency, and controlled release pattern. Transmission electron microscope and dynamic light scattering analysis demonstrated a size range of 181-245 nm and a zeta potential range of 20-30 mV. The stability of the formulation was demonstrated by thermal studies. Cytotoxicity and cellular interaction of cisplatin-loaded LPHNP were investigated using in vitro cell-based assays using the A2780 ovarian carcinoma cell line. The pharmacokinetics study in rabbits supported a controlled delivery of cisplatin with enhanced mean residence time and half-life. These studies suggest that cisplatin loaded LPHNP have promise as a platform for controlled delivery of cisplatin in cancer therapy.
Keywords: Cisplatin; chitosan; controlled release; lipid-polymer hybrid nanoparticles; ovarian cancer; pharmacokinetics.
Figures





References
-
- Acharya S, Sahoo SK (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–83. - PubMed
-
- Alam N, Khare V, Dubey R, et al. (2014). Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile. Mater Sci Eng C 38:85–93. - PubMed
-
- Avgoustakis K, Beletsi A, Panagi Z, et al. (2002). PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 79:123–35. - PubMed
-
- Barbieri S, Sonvico F, Como C, et al. (2013). Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake. J Control Release 167:276–83. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources